Clinical outcomes after early ambulatory multidrug therapy for high-risk SARS-CoV-2 (COVID-19) infectionArticle Published on 2020-12-302023-07-13 Journal: Rev Cardiovasc Med [Category] SARS, [키워드] ambulatory Antiviral Azithromycin Corticosteroid COVID-19 doxycycline Hospitalization Hydroxychloroquine Ivermectin Mortality multidrug SARS-CoV-2 Vitamin zinc. [DOI] 10.31083/j.rcm.2020.04.260 PMC 바로가기